Alpha DNA Investment Management »

Corcept Therapeutics Incorporated shares owned by Alpha DNA Investment Management

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Alpha DNA Investment Management from 13F filings

Historical chart of Alpha DNA Investment Management investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Alpha DNA Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Alpha DNA Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $464k 10k 46.28

More positions owned by Alpha DNA Investment Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Wal-Mart Stores (WMT)
Apple (AAPL)
Bank of America Corporation (BAC)
JPMorgan Chase & Co. (JPM)
Nextera Energy (NEE)
Honeywell International (HON)
Microsoft Corporation (MSFT)
Verizon Communications Call Option (VZ)
Philip Morris International (PM)
Arista Networks (ANET)
Abbvie (ABBV)
Chubb (CB)
Texas Instruments Incorporated (TXN)

View all positions for Alpha DNA Investment Management

Top funds holding Corcept Therapeutics Incorporated

BlackRock
BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
Dimensional Fund Advisors
Novo A/S
Geode Capital Management
Arrowstreet Capital, Limited Partnership
Btim
First Trust Advisors
Morgan Stanley
Jacobs Levy Equity Management

View all funds holding Corcept Therapeutics Incorporated